Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.
Keating, Katie M; Brewer, Noel T; Gottlieb, Sami L; Liddon, Nicole; Ludema, Christina; Smith, Jennifer S.
J Adolesc Health
; 43(4 Suppl): S61-7, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18809147
Two Basic Scientists Walk into a Translational Space.
A Prize for Cancer Prevention.
Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.
[Human papillomavirus infection and vaccination].
The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.
Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).
Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women - United States, 2008 and 2016.
HPV-9 e prevenzione dei tumori HPV correlati: stato dell'arte, potenziali benefici e problemi aperti.